Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study

Awareness and Education

August 2, 2016 Vincent J. Gnanapragasam [ultimate_spacer height=”32″] Abstract Introduction Over 80% of the nearly 1 million men diagnosed with prostate cancer annually worldwide present with localised or locally advanced non-metastatic disease. Risk stratification is the cornerstone for clinical decision making and treatment selection for these men. The most widely applied stratification systems use presenting…

Boston Business Journal chose AdMeTech President and CEO Dr. Faina Shtern as one of the Women of Influence

AdMeTech In The News

Women of Influence: AdMeTech Foundation Chief Faina Shtern takes on prostate cancer. After she emigrated from the Soviet Union as a Jewish refugee escaping oppression, Faina Shtern knew what she wanted to do once she landed in America in the late 1970s: medical research.

With a medical degree from Chemovets Medical School in the Ukraine, Shtern proceeded to pursue her dream, eventually working at a number of prestigious institutions over the years, including being appointed a clinical and research fellow at Massachusetts General Hospital and Harvard Medical School, where she subsequently became a faculty member.